Logo

    hiv epidemic

    Explore " hiv epidemic" with insightful episodes like "Episode 1 - 40 Years Later: Looking Back at The Beginning of The HIV/AIDS Epidemic", "Ending the HIV Epidemic: Persistence on ART", "My Lived Experience as a Woman Aging With HIV", "Ending the HIV Epidemic: Keys to Successful Treatment Initiation" and "Ending the HIV Epidemic: Reaching the Undiagnosed" from podcasts like ""Going anti-Viral", "CCO Infectious Disease Podcast", "CCO Infectious Disease Podcast", "CCO Infectious Disease Podcast" and "CCO Infectious Disease Podcast"" and more!

    Episodes (13)

    Episode 1 - 40 Years Later: Looking Back at The Beginning of The HIV/AIDS Epidemic

    Episode 1 - 40 Years Later: Looking Back at The Beginning of The HIV/AIDS Epidemic

    Episode 1 - 40 Years Later: Looking Back at the Beginning of the HIV/AIDS Epidemic

    In this episode of Going anti-Viral, we revisit a panel discussion titled "40 Years Later: Looking Back at the Beginning of the HIV/AIDS Epidemic," sponsored by the IAS–USA. 


    Dr Gerald Friedland moderates a panel of key medical figures who served at the frontlines of the HIV/AIDS epidemic during its early years. The panel, consisting of Dr Kathryn Anastos, Dr Donna Futterman, Dr Sheldon Landesman, and Dr Fred Valentine discusses their experiences, the systemic responses, and the stigma associated with the disease. They contemplate on how the lessons learned from HIV are relevant to the current COVID-19 pandemic and the potential pandemics that may come in the future.


    The discussion took place on June 13, 2022, at the Scott M. Hammer Annual Update on HIV Management in New York City.


    00:00 Introduction and Overview of the Podcast

    00:37 Panel Discussion: Reflecting on the Early Days of the HIV Epidemic

    01:20 Panelists Share Their Personal Experiences and Challenges

    02:29 The Impact of HIV on Medical Professionals and Their Careers

    03:01 The Spread of HIV in Different New York City Boroughs

    03:45 Panelists' Current Roles and Their Initial Encounters with HIV

    06:01 The Struggle with Internalized Homophobia in HIV Patients

    06:26 The Evolution of HIV Treatment and the Reaction of Medical Providers

    07:44 The Emotional Impact of the HIV Epidemic

    20:06 The Challenges of Creating a System of Care for HIV Patients

    21:23 The Stigma and Misunderstandings Surrounding HIV

    40:29 The Role of Activism in the Fight Against HIV

    41:35 Institutional Responses to the HIV Epidemic

    43:21 Challenges in Pediatric Care for HIV Patients

    44:10 Stigma and Discrimination in Healthcare

    44:47 International Efforts in HIV Testing

    47:01 Safety Measures in HIV Research Labs

    48:43 Health and Hospitals Corporation's Role in HIV Care

    50:01 The Impact of HIV on Medical Education and Training

    54:11 The Role of Activism in the HIV/AIDS Response

    55:40 Lessons from HIV for Future Pandemics

    57:16 The Response of the Medical Community to HIV

    58:21 The Importance of Addressing Social Determinants of Health

    01:00:08 The Future of HIV Research and Care

    01:06:34 Closing Remarks and Reflections

    __________________________________________________

    Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

    Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

    Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

    Follow Going anti-Viral on:
    Apple Podcasts
    YouTube
    Instagram
    TikTok
    ...

    Ending the HIV Epidemic: Persistence on ART

    Ending the HIV Epidemic: Persistence on ART

    In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD​, discusses strategies for and importance of HIV care engagement and reengagement for those who have fallen out of care. Her overview includes:

    • WHO Global Health Strategy on HIV
    • Longitudinal HIV care trajectories
    • Promotion of successful care and antiretroviral therapy (ART) adherence
    • Differentiated service delivery
    • Improving care and ART adherence in high-risk groups
    • Patient perspectives on ART persistence 

    Presenter:
    Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
    Director
    Desmond Tutu HIV Centre​
    Past President
    International AIDS Society​
    Faculty of Health Sciences
    University of Cape Town
    Cape Town, South Africa​

    Panelists:
    Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD​
    Chief and Director
    VHS-Infectious Diseases Medical Centre​
    Director
    Chennai Antiviral Research and Treatment (CART) Clinical Research Site​
    Voluntary Health Services​
    Chennai, India

    Chloe Orkin, MBChB, FRCP, MD​
    Professor of HIV
    Queen Mary, University of London​
    Consultant Physician​
    Lead for HIV Research
    Barts Health NHS Trust​
    The Royal London Hospital​
    London, United Kingdom​

    Babafemi Taiwo, MBBS​
    Gene Stollerman Professor of Medicine​
    Chief, Division of Infectious Diseases​
    Northwestern University 
    Feinberg School of Medicine​
    Chicago, Illinois

    Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

    Follow along with the slides: 
    https://bit.ly/3dSNoum

    Link to full program:
    https://bit.ly/3AE2AV1

    My Lived Experience as a Woman Aging With HIV

    My Lived Experience as a Woman Aging With HIV

    In this podcast, Melanie Reese, a woman aging with HIV, shares her perspectives on the added challenges faced by older women with HIV—an underserved, underresourced, and underresearched group—and talks about potential solutions that should be considered, such as:

    • Listen and prioritize concerns brought to you by older women with HIV to improve trust in you and the medical profession
    • Promote self-advocacy for women to improve their interactions with healthcare professionals, such as opening the dialogue about sexual health
    • Support mental health by ensuring a baseline neurologic exam to monitor for any cognitive decline
    • Emphasize the importance of self-care and prioritizing oneself
    • Address psychosocial issues by finding ways for patients to connect with others
    • Advocate to change policies, standards of care, and laws that govern all places that care for those who are aging and need assistance in care

    Faculty
    Melanie Reese
    Subject Matter Expert, HIV Aging
    Technical Expert Panel
    Health Resources and Services Administration
    HIV/AIDS Bureau
    Baltimore, Maryland

    Link to full program: 
    https://bit.ly/3KkF4iZ

    Ending the HIV Epidemic: Keys to Successful Treatment Initiation

    Ending the HIV Epidemic: Keys to Successful Treatment Initiation

    In this episode, Chloe Orkin, MBChB, FRCP, MD​, discusses strategies for successful antiretroviral therapy (ART) initiation. Her overview includes:

    • Recommendations for rapid ART
    • First-line ART regimens for treatment-naive people with HIV
    • IMEA 055 FAST study
    • STAT study
    • DIAMOND study
    • Antiretroviral resistance mutations
    • Patient perspectives on the importance of rapid ART initiation

    Presenter:

    Chloe Orkin, MBChB, FRCP, MD
    Professor of HIV
    Queen Mary, University of London​
    Consultant Physician​
    Lead for HIV Research
    Barts Health NHS Trust​
    The Royal London Hospital​
    London, United Kingdom​

    Panelists:

    Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD​
    Director
    Desmond Tutu HIV Centre​
    Past President
    International AIDS Society​
    Faculty of Health Sciences
    University of Cape Town
    Cape Town, South Africa​

    Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD​
    Chief and Director
    VHS Infectious Diseases Medical Centre​
    Director, Chennai Antiviral Research and Treatment (CART) Clinical Research Site​
    Voluntary Health Services​
    Chennai, India

    Babafemi Taiwo, MBBS​
    Gene Stollerman Professor of Medicine​
    Chief, Division of Infectious Diseases​
    Northwestern University
    Feinberg School of Medicine​
    Chicago, Illinois

    Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

    Follow along with the slides: 
    https://bit.ly/3dSNoum

    Link to full program:
    https://bit.ly/3AE2AV1

    Ending the HIV Epidemic: Reaching the Undiagnosed

    Ending the HIV Epidemic: Reaching the Undiagnosed

    In this episode, Babafemi Taiwo, MBBS, discusses strategies for reaching people with HIV who are not yet diagnosed. His overview includes:

    • HIV diagnosis by global region
    • Disparities in serostatus awareness
    • Patient perspective on importance of HIV testing
    • Barriers to HIV diagnosis
    • Complications from late HIV diagnosis
    • Strategies to improve rates of HIV testing

    Presenter:

    Babafemi Taiwo, MBBS​
    Gene Stollerman Professor of Medicine​
    Chief, Division of Infectious Diseases​
    Northwestern University
    Feinberg School of Medicine​
    Chicago, Illinois

    Panelists:

    Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
    Director
    Desmond Tutu HIV Centre​
    Past President
    International AIDS Society​
    Faculty of Health Sciences
    University of Cape Town
    Cape Town, South Africa​

    Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD​
    Chief and Director
    VHS Infectious Diseases Medical Centre​
    Director, Chennai Antiviral Research and Treatment (CART) Clinical Research Site​
    Voluntary Health Services​
    Chennai, India

    Chloe Orkin, MBChB, FRCP, MD
    Professor of HIV
    Queen Mary, University of London​
    Consultant Physician​
    Lead for HIV Research
    Barts Health NHS Trust​
    The Royal London Hospital​
    London, United Kingdom​

    Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

    Follow along with the slides: 
    https://bit.ly/3PJRthD

    Link to full program:
    https://bit.ly/3AE2AV1

    My Perspective: Living With HIV Is Life Changing but Not Life Limiting

    My Perspective: Living With HIV Is Life Changing but Not Life Limiting

    In this episode, Yvette Raphael provides her perspectives and advice as an individual living with HIV in South Africa for more than 20 years. She shares her experiences and ideas for how to improve processes related to HIV diagnosis, care linkage, and treatment.

    Presenter:

    Yvette Raphael

    Content based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.

    Link to full program:
     https://bit.ly/3tmgozy

    An HIV Vaccine: An Unfulfilled Promise—Episode 4, Looking Toward a Fulfilled Promise

    An HIV Vaccine: An Unfulfilled Promise—Episode 4, Looking Toward a Fulfilled Promise

    Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode,Drs Elizabeth Bukusi, Peter Godfrey-Faussett, and Nina Russell discuss promising advances in the field of HIV vaccine research and how we can prepare for optimal rollout of an eventual HIV vaccine. 

    Presenters:

    Elizabeth Anne Bukusi, MBChB, M.Med (ObGyn), MPH, PhD , PGD (Research Ethics), MBE (Research Ethics), CIP
    Senior Principal Clinical Research Scientist
    Center for Microbiology Research
    KEMRI
    Research Professor
    Departments of Global Health and Obstetrics and Gynecology
    University of Washington,
    Nairobi, Kenya
    Seattle, Washington

    Peter Godfrey-Faussett, MBBS, FRCP(UK)
    Science Advisor
    United Nations Joint Programme on HIV (UNAIDS)
    Professor of Infectious Diseases and International Health
    London School of Hygiene and Tropical Medicine
    London, United Kingdom

    Nina Russell, MD
    Director for TB and HIV Prevention
    Bill & Melinda Gates Foundation
    Seattle, Washington


    Link to full series:  
    https://bit.ly/2UgrQ12

    Link to the HIV unmuted series from IAS: https://hivunmuted.iasociety.org/

    Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.

    An HIV Vaccine: An Unfulfilled Promise—Episode 3, Increasing Global Advocacy and Funding

    An HIV Vaccine: An Unfulfilled Promise—Episode 3, Increasing Global Advocacy and Funding

    Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Swati Gupta and Mr. Marc Dixneuf discuss how to broaden global advocacy and increase investment for an HIV vaccine.

    Presenters:

    Swati Gupta, DrPH, MPH
    Vice President and Head of Emerging Infectious Diseases and Scientific Strategy
    International AIDS Vaccine Initiative
    New York, New York

    Marc Dixneuf, PhD
    Director General
    AIDES
    Pantin, France

    Special Commentator:  

    Jonathan Weber, MB, BChir, PhD, FRCP, FRCPath, FMed Sci
    Dean of the Faculty of Medicine
    Imperial College
    London, United Kingdom

    Link to full series:
    https://bit.ly/3ytytMY

    Link to the HIV unmuted series from IAS:
    https://bit.ly/3f5qC0d

    Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.

    An HIV Vaccine: An Unfulfilled Promise—Episode 2, Learning Through Failing

    An HIV Vaccine: An Unfulfilled Promise—Episode 2, Learning Through Failing

    Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Susan Buchbinder and Mr. Jontraye Davis discuss what has been learned and built through the past 40 years of HIV vaccine research, including how HIV vaccine scientific advancements and infrastructure were critical to the success of developing a COVID-19 vaccine.

    Presenters:

    Susan Buchbinder, MD
    Clinical Professor
    Departments of Medicine, Epidemiology and Biostatistics
    University of California, San Francisco
    Director, Bridge HIV
    San Francisco Department of Public Health
    San Francisco, California  

    Jontraye Davis, MHA, PMD Pro
    Community Program Manager 
    FHI 360
    Adjunct Instructor
    North Carolina Central University
    Durham, North Carolina

    Special Commentator:  

    Jerome H. Kim, MD
    Director General
    International Vaccine Institute
    Seoul, South Korea

    Link to full series:
    https://bit.ly/3ytytMY

    Link to the HIV unmuted series from IAS:
    https://bit.ly/3f5qC0d

    Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.

    An HIV Vaccine: An Unfulfilled Promise− Episode 1, The Ultimate Game Changer

    An HIV Vaccine: An Unfulfilled Promise− Episode 1, The Ultimate Game Changer

    Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this first episode, Dr. Linda-Gail Bekker and Ms. Maureen Luba discuss why an HIV vaccine remains the ultimate game-changer to ending the epidemic and the gaps it will address in the expanding HIV prevention landscape.

    Presenters:

    Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD  
    Chief Operating Officer  
    Desmond Tutu HIV Foundation  
    Deputy Director
    Desmond Tutu HIV Centre  
    Past President
    International AIDS Society  
    Faculty of Health Sciences  
    University of Cape Town  
    Cape Town, South Africa

    Maureen Luba
    Africa Region Advocacy Advisor
    Global Advocacy for HIV Prevention
    AIDS Vaccine Advocacy Coalition

    Link to full series:
    https://bit.ly/3ytytMY

    Link to the HIV unmuted series from IAS:
    https://bit.ly/3f5qC0d

    Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.

     

    Ending the HIV Epidemic: Strategies for Preventing New Infections

    Ending the HIV Epidemic: Strategies for Preventing New Infections

    In this episode, the third in a 3-part series on Ending the HIV Epidemic,  Judith Feinberg, MD, and  Kenneth Mayer, MD, discuss the important role of HIV pre-expsoure prophylaxis (PrEP) for preventing HIV infection among at-risk individuals and critical strategies for effective PrEP implementation among principle populations, including men who have sex with men and transgender women, heterosexual cisgender women, and people who inject drugs. Following their dialogue, the faculty field clinician questions on HIV prevention.

    Presenters:

    Judith Feinberg, MD
    Professor
    Attending Physician
    Departments of Medicine and Behavioral Medicine & Psychiatry
    West Virginia University School of Medicine
    Morgantown, West Virginia

    Kenneth Mayer, MD
    Infectious Disease Attending
    Beth Israel Deaconess Medical Center
    Professor of Medicine
    Harvard Medical School
    Medical Research Director
    Fenway Community Health
    Boston, Massachusetts

    Content based on an online CME program supported by educational grants from Gilead Sciences and ViiV Healthcare and produced in collaboration with PCE and HealthHIV.

    Link to full program:
    http://bit.ly/3263Q1s

    Ending the HIV Epidemic: Strategies for Achieving Rapid and Durable Virologic Suppression

    Ending the HIV Epidemic: Strategies for Achieving Rapid and Durable Virologic Suppression

    In this episode, the second in a 3-part series on Ending the HIV Epidemic, Jason Halperin, MD, MPH, and Aadia I. Rana, MD, discuss treatment as prevention, the critical infrastructure needed to implement rapid ART, the importance of routinely assessing for barriers to care, and real-time monitoring strategies that improve patient adherence and engagement. Following their dialogue, the faculty field clinician questions on HIV treatment and retention in care.

    Presenters:

    Jason Halperin, MD, MPH
    Assistant Professor of Medicine
    Department of Infectious Diseases
    Tulane University
    Infectious Disease Physician
    CrescentCare
    New Orleans, Louisiana

    Aadia I. Rana, MD
    Associate Professor of Medicine
    Division of Infectious Diseases 
    The University of Alabama at Birmingham 
    1917 Clinic
    Birmingham, Alabama

    Content based on an online CME program supported by educational grants from Gilead Sciences and ViiV Healthcare and produced in collaboration with PCE and HealthHIV.

    Link to full program:
    https://bit.ly/3263Q1s

    Ending the HIV Epidemic: Strategies for Earlier Diagnosis, Linkage to Care, and Outbreak Response

    Ending the HIV Epidemic: Strategies for Earlier Diagnosis, Linkage to Care, and Outbreak Response

    In this episode, the first in a 3-part series on Ending the HIV Epidemic, Lisa K. Fitzpatrick, MD, MPH, MPA, and David Malebranche, MD, MPH, discuss strategies to expand early HIV testing, maximize patient engagement in HIV care, navigate emerging clusters of HIV infection, and combat HIV-related stigma. Following their dialogue, the faculty field clinician questions on HIV diagnosis and management.  

    Presenters:

    Lisa K. Fitzpatrick, MD, MPH, MPA
    Professorial Lecturer
    Department of Epidemiology
    George Washington University School of Public Health
    Interim Medical Director
    BlueRock Care
    Washington, DC

    David J. Malebranche, MD, MPH
    Board-Certified Internal Medicine Physician
    HIV Specialist

    Content based on an online CME program supported by educational grants from Gilead Sciences and ViiV Healthcare and produced in collaboration with PCE and HealthHIV.

    Link to full program:
    https://bit.ly/3263Q1s  

     

    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io